Navigation Links
Rochester Medical Implants Achieves ISO 13485:2003 Certification for Medical Device Manufacturing
Date:9/25/2008

Certification Reflects Contract Manufacturing Company's Commitment to

High-Quality Standards and Stringent Compliance Guidelines

ROCHESTER, Ind., Sept. 25 /PRNewswire/ -- Rochester Medical Implants (http://www.rmi.us.com), a contract manufacturer of high-precision spinal and orthopaedic implants and instruments, announced today that it has achieved ISO 13485:2003 certification through auditor NSF International.

"Building upon our existing ISO 9001:2000 quality system, the ISO 13485:2003 certification process has been a major business initiative of our company and reflects the organization's commitment to manufacturing high-quality products for the medical device market," commented James K. Evans, President of Rochester Medical Implants. "Achieving this important objective sets RMI apart from many of our competitors and offers our customers a quality partner able to help them achieve their business initiatives."

Rochester Medical Implants, located in Rochester, Indiana, is a team of medical device manufacturing professionals bringing expertise to the entire product realization process. Whether working with customers to launch new technologies or improve existing devices, RMI innovates manufacturing processes that allow for improved quality and superior time to market. The company's core competencies include fully integrated services in CAD/CAM engineering, 5-axis CNC milling, turning and wire EDM, process development, material sourcing, laser marking, assembly and packaging.

ISO 13485:2003 applies to organizations involved with the product design, engineering and contract manufacturing services for medical device customers. The RMI facility, which includes a dedicated isolation room for the fabrication of implant grade PEEK-Optima products, can accommodate manufacturing, assembly and packaging of a wide variety of medical devices. The ISO certification process ensures ongoing compliance as companies are externally audited every twelve months.

RMI's quality policy says it all, "Critical products manufactured to the highest quality standards, first time, every time!"

Rochester Medical Implants serves as a subcontract manufacturer for large OEM suppliers of surgical orthopaedic products, as well as custom design houses working with leading orthopaedic surgical groups developing innovative implants and instruments. Many of our customers do not have in-house manufacturing capability and rely exclusively on RMI to prove out concepts, develop prototypes, provide assistance with design for manufacturability (DFM), and satisfy their production needs with short lead times. RMI is an SBA Certified HUBZone firm and maintains FDA registration for customer products.

Rochester Medical Implants is located in Rochester, Indiana. For more information visit http://www.rmi.us.com, email us at info@rmi.us.com, or call 574.223.8198.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Rochester Medical Implants
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. U.S. Reps. Oberstar and Walz Discuss DM&E Railroad Expansion With Rochester, Minn. Leaders
2. Rochester Medical Reports Record Fourth Quarter Sales and Record Year
3. Rochester Medical Announces First Quarter 2008 Earnings Conference Call February 4, 2008
4. Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger
5. Rochester Medical Applauds Improved U.S. Medicare Coverage Policy for Intermittent Catheters
6. Rochester Medical Marketing VP Retires
7. Rochester Coalition and Mayo Clinic Challenge Railroads Contention That Hazmat Rail Shipments Pose no Risk
8. Rochester Medical Honored by Premier Healthcare Alliance for Exceeding Performance Expectations
9. Autovan Donates Wheelchair-Accessible Van; Brings Greater Mobility to Facility in Rochester, New York
10. MSU engineering team designs innovative medical device
11. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 Executive Forum, taking ... of the country’s top healthcare executives to share insights on transformational strategies to ... Forum is the provider-centric perspective, experience, expertise and strategy shared by the participants,” ...
(Date:2/10/2016)... MA (PRWEB) , ... February 10, 2016 , ... Gout ... switch, and brings pain that is often severe, with intense swelling and redness. It ... than eight million people, but older adults are the most susceptible, according to the ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA blood ... exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric ... in their patients. Research shows that the Goal Attainment Scale (GAS) captures 20% ... this challenge and learn more about the Goal Attainment Scale, Education Resources Inc. ...
(Date:2/10/2016)... ... February 10, 2016 , ... A ... Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's Bureau of ... , As the longest running and largest worker's compensation event in Ohio, ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... LONDON , February 10, 2016 ... 2016, which will be held at Victoria Park Plaza in ... host an informative seminar on technology and future advances for ... seminar, led by Lorna Graham , associate director of ... technology to keep up with new regulations and standards in ...
(Date:2/10/2016)... ATLANTA , Feb. 10, 2016  LexisNexis® ... and technology, today announced the launch of ... analytics solution that helps improve and optimize the ... evaluation of performance using severity-adjusted scores. By measuring ... a critical solution to deliver better outcomes, improve ...
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... biopharmaceutical company developing novel, clinical-stage therapies for sickle cell ... an underwritten public offering of 29,090,910 units at a ... unit consists of one share of the Company,s common ... the Company,s common stock at an exercise price of ...
Breaking Medicine Technology: